(Q37815309)

23 August 2017

title

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer? (English)

1 reference

23 August 2017

1 reference

1

0 references

Molly S. Daniels

2

0 references

Eric Boerwinkle

6

object named as

Eric Boerwinkle

0 references

Diane C. Bodurka

object named as

Diane C Bodurka

7

0 references

Karen H. Lu

10

object named as

Karen H Lu

1 reference

23 August 2017

8

David M Gershenson

1 reference

23 August 2017

Diana L Urbauer

3

1 reference

23 August 2017

Michael T Deavers

4

1 reference

23 August 2017

Charlotte C Sun

5

1 reference

23 August 2017

Jessica Crawford

9

1 reference

23 August 2017

language of work or name

English

0 references

publication date

3 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

120

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

229-232

1 reference

Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Early events in the pathogenesis of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Diverse tumorigenic pathways in ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Grading ovarian serous carcinoma using a two-tier system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

Validity of models for predicting BRCA1 and BRCA2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.10.033

10.1016/J.YGYNO.2010.10.033

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference